HomeOwner SearchCategory Search
Visit USCOProceedings of SPIE- Colloidal Nanoparticles for Biomedical Applications XV [Published: 2020-03-26. Issue: vol. 11255, 1-3 February 2020]
Serial Registration
Copyright Title
Proceedings of SPIE- Colloidal Nanoparticles for Biomedical Applications XV [Published: 2020-03-26. Issue: vol. 11255, 1-3 February 2020]
Status
Published
on 18 May 2020
Year of Creation
2020
Copyright Claimant
SPIE
Registration Number
TX0008874051
on 18 May 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008874051) dated 18 May 2020, pertains to an electronic file (eService) titled "Proceedings of SPIE- Colloidal Nanoparticles for Biomedical Applications XV [Published: 2020-03-26. Issue: vol. 11255, 1-3 February 2020]" created in 2020. The copyright holder is SPIE, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to SPIE.
Application Details
Registration Number
TX0008874051
Registration Date
5/18/2020
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
SPIE
First Publication Nation
United States
ISSN
1605-7422
Notes
Rights Note: SPIE, PO Box 10, Bellingham, WA, 98227-0010, United States
Copyright Local Holdings: vol. 11255, 1-3 February 2020 Created 2020 Pub. 2020-03-26 Reg. 2020-05-18 TX0008874051 JALG
Statements
Application Title Statement: Proceedings of SPIE- Colloidal Nanoparticles for Biomedical Applications XV
Author Statement: SPIE employer for hire Domicile: United States Citizenship: United States Authorship: Collective Work Authorship and Component Work(s) authored or fully owned by the Collective Work Author
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.